Tag: ESC 2026

Abbott has announced late-breaking, 12-month data from the global FlexPulse investigational device exemption (IDE) study that show favourable safety and effectiveness outcomes for its...

Early electrocardiogram (ECG) monitoring initiated in the emergency department (ED) has the potential to transform the care of thousands of patients who attend the...

Edoxaban—an oral anticoagulant medication—failed to reduce stroke or systemic embolism but did increase major bleeding in high-risk patients with atrial fibrillation (AF) who had...

While younger patients appeared to benefit, implantable cardioverter-defibrillators (ICDs) did not improve the primary endpoint overall in the CMR GUIDE trial, according to new...

Targeted placement of a left ventricular lead does not improve outcomes in patients with heart failure undergoing cardiac resynchronisation therapy (CRT), according to results presented...

Catheter ablation for atrial fibrillation (AF) did not significantly improve AF-related quality of life compared with a sham procedure, despite reducing AF recurrence, as...

Routine concomitant closure of the left atrial appendage (LAA) during open-heart surgery should not be considered unless patients are high risk for stroke, results...